Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nippon Kayaku Licensed Paclitaxel DDS from NanoCarrier
July 22, 2002
- Korosho Panel Recommends GLs for Infertility Therapy
July 22, 2002
- Fujisawa Licenses Cefzon to Xian-Janssen in China
July 22, 2002
- GL to Include MNZ in Secondary H. pylori Eradication Therapy
July 22, 2002
- Wholesaler-Maker Relationship Undergoing Drastic Changes: Mr Akiyama of Suzuken
July 22, 2002
- Olympus Codevelops New DNA Microarray System with PamGene
July 22, 2002
- Kuraya Sanseido Acquires ATOL's Business in Tokyo, Kanagawa
July 22, 2002
- Sankyo Pharma to Market Cygnus' GlucoWatch
July 22, 2002
- MOSS Institute to Be Listed on August 8
July 22, 2002
- Shionogi-GSK Announces 1st Clinical Trial Results for New Anti-HIV Drug
July 22, 2002
- Number of Wholesalers to Decrease to 3 to 40 by 2011: YRI Report
July 22, 2002
- First Study on Palliative Medicine in Japan Completed
July 22, 2002
- Monkasho Holds Symposium on National Bioresources Project
July 22, 2002
- WORLD NEWS IN BRIEF
July 22, 2002
- BUSINESS NEWS IN BRIEF -1-
July 22, 2002
- SSP Aims at 5.7% Sales Rise in Self-Medication Division
July 22, 2002
- BUSINESS NEWS IN BRIEF -2-
July 22, 2002
- MEDICAL DEVICE NEWS IN BRIEF
July 22, 2002
- NEW PRODUCTS
July 22, 2002
- Roche Diagnostics Starts Mouse DNA Chip Consortium
July 22, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…